Clinical Trial Update: Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing cetuximab from Cinnagen with Erbitux in metastatic colorectal cancer; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (CinnaGen) (cetuximab)
• ERBITUX (cetuximab)

Snippet

Sponsor: Cinnagen | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN